Education
About Us
Working with TipRanks
Follow Us
Molecular Templates, Inc. (MTEMQ)
:MTEMQ
MTEMQ Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MTEMQ FAQ
What was Molecular Templates, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Molecular Templates, Inc.’s market cap?
Currently, no data Available
When is Molecular Templates, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Molecular Templates, Inc.’s earnings last quarter?
Currently, no data Available
Is Molecular Templates, Inc. overvalued?
According to Wall Street analysts Molecular Templates, Inc.’s price is currently Undervalued.
Does Molecular Templates, Inc. pay dividends?
Molecular Templates, Inc. does not currently pay dividends.
What is Molecular Templates, Inc.’s EPS estimate?
Molecular Templates, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Molecular Templates, Inc. have?
Currently, no data Available
What happened to Molecular Templates, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Molecular Templates, Inc.?
Currently, no hedge funds are holding shares in MTEMQ
Company Description
Molecular Templates, Inc.
Molecular Templates, Inc. (MTEM) is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics. The company operates primarily in the biotechnology sector, utilizing its proprietary engineered toxin body platform technology to create novel therapies aimed at treating cancer and other serious diseases. Molecular Templates strives to enhance the potency and specificity of its therapeutics to improve patient outcomes.
Molecular Templates (MTEMQ) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.